BioNTech
NEWS
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 28, 2020.
Despite the domination of the news cycle by the COVID-19 pandemic, quite a number of biopharma companies reported on non-COVID-19 clinical trials last week, although there remains plenty of ongoing trial news related to the pandemic. Here’s a look.
It’s likely that more companies and universities will add additional assets as time goes on.
It was a very busy week for clinical trial news. Here’s a look.
Pfizer and BioNTech updated their development program, with plans to launch clinical trials in the U.S. and Europe across multiple sites by the end of April.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 9, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.
While the world is working to slow the COVID-19 pandemic by social isolation and quarantine, numerous companies globally are working to develop a vaccine against the virus.
The two companies will focus on BioNTech’s BNT162, an mRNA-based vaccine candidate.
JOBS
IN THE PRESS